Tingxi Guo

5PUBLICATIONS
5CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2026
A synthetic NKG2A engager enables long-term persistence of HLA-deficient allogeneic engineered Tregs.

|May 17, 2018
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models.

Yuki Kagoya, Munehide Nakatsugawa, Kayoko Saso

|Mar 21, 2018
Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP84Gly.

Mark Anczurowski, Yuki Yamashita, Munehide Nakatsugawa

|Feb 06, 2018
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects.

Yuki Kagoya, Shinya Tanaka, Tingxi Guo

|Dec 15, 2017
A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1+ TCRs.

Tingxi Guo, Ming Yin Koo, Yuki Kagoya

Pageof 1

Frequent Collaborators

4 joint publications

Marcus O Butler

4 joint publications

Naoto Hirano

1 joint publications

Yuki Kagoya

1 joint publications

Kaya R Epstein